rick bright barda email kansas obituary decatur il brighton linkedin and bill gates aspr american home shield architect tucson associates a. ph.d nelson lights country music bio hometown doctor democrat illinois dr eureka springs fox news forbes facebook ross future lyrics sample hhs miller horizons letter macon county park shore mortgage nih new york times novavax & oleson screen phd political party rv bryson tiller statement shine twitter trump wakeman all things beautiful vaccine wikipedia wife
Dr. Rick Bright (Top Vaccine Doctor) Bio, Wiki, Age, Wife, Family, Education, BARDA Director, Salary
Dr. Rick Bright led BARDA, the biomedical advanced research and development authority, from 2016 to Tuesday, April 22, 2020, when he was reassigned to a narrower position.
Dr Rick Bright Education
Dr. Bright obtained his Ph.D. in immunology and molecular pathogenesis from Emory University (Atlanta, GA) and his BS in biology (medical technology) and natural sciences from Auburn University (Montgomery, AL).
Dr Rick Bright BARDA
Dr. Bright joined BARDA in 2010 to lead the BARDA Influenza Division International Program, supporting programs to build and improve global capacity for the production and evaluation of flu vaccines in developing countries. He was an international materials expert in the fields of influenza, vaccines and therapeutic development and diagnostic programs. He was also an adviser to the World Health Organization and the U.S. Department of Defense.
Bright was called in at the end of 2016 to lead the division program. He was responsible for preparing the nation for flu pandemics and coordinating the production, acquisition and delivery of medical countermeasures during a pandemic response. In this role, he led a portfolio of projects for advanced development of vaccines, therapeutics, diagnostics and respiratory equipment to help in response and protection against pandemic and seasonal flu.
BARDA is a small but powerful agency with remarkable purchasing power. Although little known, it is especially critical during a pandemic, and therefore the abrupt departure of Bright surprised his colleagues. It is involved in the course of the walk and offers medical countermeasures against man-made and natural threats, including chemical, biological, radiological and nuclear threats, pandemic influenza and emerging infectious diseases. BARDA fulfills this mission by supporting product innovation, advanced development, acquisition and storage and building production infrastructure.
Dr. Rick Bright leaves director BARDA
Dr. Bright, who was the director of the office involved in the development of a coronavirus vaccine, says he was abruptly fired on April 22, 2020 for opposing efforts to broaden the availability of a Coronavirus treatment driven by President Donald Trump.
Dr. Bright had led BARDA, the biomedical advanced research and development authority, from 2016 to Tuesday when he was reassigned to a narrower function. He also announced that he will file a whistleblower complaint with the Inspector General of the Department of Health and Human Services.
Dr Bright cited “clashes with political leadership” as the reason for his offside, as well as his opposition to “attempts to promote potentially dangerous drugs promoted by people with political connections.”
According to a spokesman for the Department of Health and Human Services (HHS), Bright’s will now lead a new government project: a public-private partnership for the development and treatment of vaccines.
“On April 17, the National Institutes of Health (NIH) announced a new public-private partnership – the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership – to accelerate the development of the COVID-19 vaccine and treatment options. At the same time, given the simultaneous importance of accelerating the development of diagnostic tests for COVID-19, Dr. Rick Bright will transfer the skills he has applied as director of the Biomedical Advanced Research and Development Authority (BARDA) to the National Institutes of Health as part of a bold plan to accelerate the development and implementation of new point-of-care testing platforms , “according to the HHS statement.
Dr. Rick Bright Twitter
He describes himself on Twitter as “Impactful, practical, innovative. Hyper focused on saving lives. All comments, likes, shares are personal and do not represent any views or policies of the USG. “